Axial involvement is present in approximately 25% of patients with PsA, with enthesitis, inflammatory bowel disease, and ...

Psoriatic arthritis (PsA) is a chronic inflammatory condition that affects approximately 112 per 100,000 adults worldwide. It ...

The following is a summary of “Health-related quality of life significantly improved in obese patients with psoriatic arthritis one year after a structured weight loss intervention,” published in the ...

The arrival of biosimilars like Celltrion's STEQEYMA and Biocon's YESINTEK is shaking up the psoriatic arthritis market, challenging blockbuster biologics with cost-effective alternatives. As ...

Steqeyma is indicated for the treatment of plaque psoriasis and psoriatic arthritis in adult and pediatric patients, as well ...

At the recent SEC meeting for analgesics and rheumatology held on February 25, 2025, the expert panel reviewed the ...

Opens in a new tab or window German investigators recently set out to determine whether inflammatory bowel disease drives the occurrence of psoriasis or psoriatic arthritis—or whether the ...

Patients receiving ICIs were associated with a greater risk of developing RA, but lower risks for SLE and SSc.

Arthritis is one of the most common chronic conditions affecting millions of people worldwide. Yet, many fail to recognize ...

Pharmaceutical company Novartis is laying off more than 400 employees at its East Hanover facility as part of a restructuring ...

Patients with osteoarthritis, but not immune-related arthritis, demonstrate increased odds for developing overactive bladder ...